Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WIN-HYPO2021: Levothyroxine for Prevention of Radiation-Induced Hypothyroidism
NCT05316922Phase 3Recruiting
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Dec 2021
- Primary completion
- Sep 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levothyroxine sodium in hypothyroidism, sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Started Dec 2021; status: recruiting.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT05316922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05316922.